Cambridge Cognition Holdings PLC (LON:COG)‘s stock had its “corporate” rating reissued by equities researchers at FinnCap in a report issued on Tuesday. They presently have a GBX 115 ($1.43) price objective on the stock. FinnCap’s price objective suggests a potential upside of 63.12% from the stock’s current price.

Shares of Cambridge Cognition Holdings PLC (LON:COG) opened at 70.50 on Tuesday. The firm’s 50-day moving average is GBX 73.11 and its 200 day moving average is GBX 54.54. The firm’s market capitalization is GBX 13.14 million. Cambridge Cognition Holdings PLC has a 12 month low of GBX 30.00 and a 12 month high of GBX 90.00.

TRADEMARK VIOLATION NOTICE: “FinnCap Reaffirms “Corporate” Rating for Cambridge Cognition Holdings PLC (COG)” was originally posted by The Cerbat Gem and is owned by of The Cerbat Gem. If you are reading this article on another site, it was copied illegally and republished in violation of U.S. & international copyright & trademark laws. The legal version of this article can be viewed at https://www.thecerbatgem.com/2016/11/29/finncap-reaffirms-corporate-rating-for-cambridge-cognition-holdings-plc-cog.html.

Cambridge Cognition Holdings PLC Company Profile

Cambridge Cognition Holdings plc and its subsidiaries develop and commercialize computerized neuropsychological tests for sale, principally in the United Kingdom, the United States and Europe. The Company’s segments include Pharmaceutical Clinical Trials, Academic Research and Healthcare Technology. The Pharmaceutical Clinical Trials segment includes products and services for use in regulated pharmaceutical clinical trials.

Receive News & Stock Ratings for Cambridge Cognition Holdings PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cambridge Cognition Holdings PLC and related stocks with our FREE daily email newsletter.